Safety and efficacy of a growth factor and cytokine-containing topical product in wound healing and incision scar management after upper eyelid blepharoplasty: A prospective split-face study

Jennifer Murdock, Mohamed S. Sayed, Mehdi Tavakoli, Dimitra M. Portaliou, Wendy Lee

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: To evaluate the efficacy and safety of a topical product containing a mixture of growth factors and cytokines on the incision scar following upper eyelid blepharoplasty. Methods: This is a prospective, single-blinded, and split-face study on patients who underwent bilateral upper eyelid blepharoplasty. Two weeks after surgery, one eye of each subject was randomized to receive Lumière Bio-Restorative Eye Cream on one eyelid incision for 12 weeks and no treatment on the other eyelid. Subjects returned at the postoperative weeks 6, 10, and 14. At each visit, patients and the investigator (who was blinded to the treated eyelid) evaluated the scar through specified questionnaires. Results: A total of 20 subjects with a mean age of 66.3±9.2 years completed the study. Minor side effects were noted in three subjects. At all-time points, all subjects thought eyelids treated with Lumière had a better scar and overall appearance than fellow eyelids (P<0.5); and 60% of patients strongly encouraged others to use the product. The investigator assessment of erythema and pigmentation revealed less erythema and pigmentation in treated eyes at the weeks 6 and 10, although the difference was statistically insignificant. Investigator assessment also revealed a better scar appearance at week 10 in treated eyes (P=0.04). All evaluation parameters were similar in both eyes at the last visit. Conclusion: Lumière eye cream shows an excellent safety profile and minimal effects on features of the incision scar following upper lid blepharoplasty. It may hasten the wound healing process considering the higher outcomes at the first weeks of application.

Original languageEnglish (US)
Pages (from-to)1223-1228
Number of pages6
JournalClinical Ophthalmology
Volume10
DOIs
StatePublished - Jun 30 2016

Fingerprint

Blepharoplasty
Eyelids
Wound Healing
Cicatrix
Intercellular Signaling Peptides and Proteins
Cytokines
Safety
Research Personnel
Pigmentation
Erythema

Keywords

  • Eye cream
  • Eyelid surgery
  • Lumière
  • Processed skin cell proteins
  • PSP®
  • Skin cream

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Safety and efficacy of a growth factor and cytokine-containing topical product in wound healing and incision scar management after upper eyelid blepharoplasty : A prospective split-face study. / Murdock, Jennifer; Sayed, Mohamed S.; Tavakoli, Mehdi; Portaliou, Dimitra M.; Lee, Wendy.

In: Clinical Ophthalmology, Vol. 10, 30.06.2016, p. 1223-1228.

Research output: Contribution to journalArticle

@article{311b67ced6dd43858833fbd7c6d0de4e,
title = "Safety and efficacy of a growth factor and cytokine-containing topical product in wound healing and incision scar management after upper eyelid blepharoplasty: A prospective split-face study",
abstract = "Purpose: To evaluate the efficacy and safety of a topical product containing a mixture of growth factors and cytokines on the incision scar following upper eyelid blepharoplasty. Methods: This is a prospective, single-blinded, and split-face study on patients who underwent bilateral upper eyelid blepharoplasty. Two weeks after surgery, one eye of each subject was randomized to receive Lumi{\`e}re Bio-Restorative Eye Cream on one eyelid incision for 12 weeks and no treatment on the other eyelid. Subjects returned at the postoperative weeks 6, 10, and 14. At each visit, patients and the investigator (who was blinded to the treated eyelid) evaluated the scar through specified questionnaires. Results: A total of 20 subjects with a mean age of 66.3±9.2 years completed the study. Minor side effects were noted in three subjects. At all-time points, all subjects thought eyelids treated with Lumi{\`e}re had a better scar and overall appearance than fellow eyelids (P<0.5); and 60{\%} of patients strongly encouraged others to use the product. The investigator assessment of erythema and pigmentation revealed less erythema and pigmentation in treated eyes at the weeks 6 and 10, although the difference was statistically insignificant. Investigator assessment also revealed a better scar appearance at week 10 in treated eyes (P=0.04). All evaluation parameters were similar in both eyes at the last visit. Conclusion: Lumi{\`e}re eye cream shows an excellent safety profile and minimal effects on features of the incision scar following upper lid blepharoplasty. It may hasten the wound healing process considering the higher outcomes at the first weeks of application.",
keywords = "Eye cream, Eyelid surgery, Lumi{\`e}re, Processed skin cell proteins, PSP{\circledR}, Skin cream",
author = "Jennifer Murdock and Sayed, {Mohamed S.} and Mehdi Tavakoli and Portaliou, {Dimitra M.} and Wendy Lee",
year = "2016",
month = "6",
day = "30",
doi = "10.2147/OPTH.S109517",
language = "English (US)",
volume = "10",
pages = "1223--1228",
journal = "Clinical Ophthalmology",
issn = "1177-5467",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Safety and efficacy of a growth factor and cytokine-containing topical product in wound healing and incision scar management after upper eyelid blepharoplasty

T2 - A prospective split-face study

AU - Murdock, Jennifer

AU - Sayed, Mohamed S.

AU - Tavakoli, Mehdi

AU - Portaliou, Dimitra M.

AU - Lee, Wendy

PY - 2016/6/30

Y1 - 2016/6/30

N2 - Purpose: To evaluate the efficacy and safety of a topical product containing a mixture of growth factors and cytokines on the incision scar following upper eyelid blepharoplasty. Methods: This is a prospective, single-blinded, and split-face study on patients who underwent bilateral upper eyelid blepharoplasty. Two weeks after surgery, one eye of each subject was randomized to receive Lumière Bio-Restorative Eye Cream on one eyelid incision for 12 weeks and no treatment on the other eyelid. Subjects returned at the postoperative weeks 6, 10, and 14. At each visit, patients and the investigator (who was blinded to the treated eyelid) evaluated the scar through specified questionnaires. Results: A total of 20 subjects with a mean age of 66.3±9.2 years completed the study. Minor side effects were noted in three subjects. At all-time points, all subjects thought eyelids treated with Lumière had a better scar and overall appearance than fellow eyelids (P<0.5); and 60% of patients strongly encouraged others to use the product. The investigator assessment of erythema and pigmentation revealed less erythema and pigmentation in treated eyes at the weeks 6 and 10, although the difference was statistically insignificant. Investigator assessment also revealed a better scar appearance at week 10 in treated eyes (P=0.04). All evaluation parameters were similar in both eyes at the last visit. Conclusion: Lumière eye cream shows an excellent safety profile and minimal effects on features of the incision scar following upper lid blepharoplasty. It may hasten the wound healing process considering the higher outcomes at the first weeks of application.

AB - Purpose: To evaluate the efficacy and safety of a topical product containing a mixture of growth factors and cytokines on the incision scar following upper eyelid blepharoplasty. Methods: This is a prospective, single-blinded, and split-face study on patients who underwent bilateral upper eyelid blepharoplasty. Two weeks after surgery, one eye of each subject was randomized to receive Lumière Bio-Restorative Eye Cream on one eyelid incision for 12 weeks and no treatment on the other eyelid. Subjects returned at the postoperative weeks 6, 10, and 14. At each visit, patients and the investigator (who was blinded to the treated eyelid) evaluated the scar through specified questionnaires. Results: A total of 20 subjects with a mean age of 66.3±9.2 years completed the study. Minor side effects were noted in three subjects. At all-time points, all subjects thought eyelids treated with Lumière had a better scar and overall appearance than fellow eyelids (P<0.5); and 60% of patients strongly encouraged others to use the product. The investigator assessment of erythema and pigmentation revealed less erythema and pigmentation in treated eyes at the weeks 6 and 10, although the difference was statistically insignificant. Investigator assessment also revealed a better scar appearance at week 10 in treated eyes (P=0.04). All evaluation parameters were similar in both eyes at the last visit. Conclusion: Lumière eye cream shows an excellent safety profile and minimal effects on features of the incision scar following upper lid blepharoplasty. It may hasten the wound healing process considering the higher outcomes at the first weeks of application.

KW - Eye cream

KW - Eyelid surgery

KW - Lumière

KW - Processed skin cell proteins

KW - PSP®

KW - Skin cream

UR - http://www.scopus.com/inward/record.url?scp=84982698698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982698698&partnerID=8YFLogxK

U2 - 10.2147/OPTH.S109517

DO - 10.2147/OPTH.S109517

M3 - Article

AN - SCOPUS:84982698698

VL - 10

SP - 1223

EP - 1228

JO - Clinical Ophthalmology

JF - Clinical Ophthalmology

SN - 1177-5467

ER -